These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 30170735)

  • 1. Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.
    Igarashi Y; Tashiro S; Enoki Y; Taguchi K; Matsumoto K; Ohge H; Suzuki H; Nakamura A; Mori N; Morinaga Y; Yamagishi Y; Yoshizawa S; Yanagihara K; Mikamo H; Kunishima H
    J Infect Chemother; 2018 Nov; 24(11):907-914. PubMed ID: 30170735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis.
    Okumura H; Fukushima A; Taieb V; Shoji S; English M
    J Infect Chemother; 2020 Jan; 26(1):43-50. PubMed ID: 31624029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal therapeutic recommendation for Clostridioides difficile infection in pediatric and adolescent populations: a systematic review and meta-analysis.
    Tashiro S; Mihara T; Okawa R; Tanaka Y; Samura M; Enoki Y; Taguchi K; Matsumoto K; Yamagishi Y
    Eur J Pediatr; 2023 Jun; 182(6):2673-2681. PubMed ID: 37000258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density.
    Kimura T; Stanhope S; Sugitani T
    J Infect Chemother; 2020 May; 26(5):438-443. PubMed ID: 32081648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications.
    Ohtani M; Yoshizawa S; Miyazaki T; Kumade E; Hirayama S; Sakamoto M; Murakami H; Maeda T; Ishii Y; Matsumoto T; Tateda K
    Jpn J Infect Dis; 2024 Sep; 77(5):281-284. PubMed ID: 38556300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective study of the efficacy and safety of metronidazole and vancomycin for Clostridioides difficile infection.
    Misawa K; Iketani O; Enoki Y; Taguchi K; Uno S; Uwamino Y; Hasegawa N; Matsumoto K
    J Infect Chemother; 2021 Oct; 27(10):1407-1412. PubMed ID: 34023223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Trend for Antibiotic Use for Clostridioides (Clostridium) difficile Infection in Japan.
    Ishii S; Muraki Y; Kusama Y; Yagi T; Goto R; Ebisui A; Kawabe A; Inose R; Ohmagari N
    Biol Pharm Bull; 2020; 43(4):693-696. PubMed ID: 32238711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity.
    Di X; Bai N; Zhang X; Liu B; Ni W; Wang J; Wang K; Liang B; Liu Y; Wang R
    Braz J Infect Dis; 2015; 19(4):339-49. PubMed ID: 26001980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral fidaxomicin versus vancomycin for the treatment of Clostridioides difficile infection: A systematic review and meta-analysis of randomized controlled trials.
    Tashiro S; Mihara T; Sasaki M; Shimamura C; Shimamura R; Suzuki S; Yoshikawa M; Hasegawa T; Enoki Y; Taguchi K; Matsumoto K; Ohge H; Suzuki H; Nakamura A; Mori N; Morinaga Y; Yamagishi Y; Yoshizawa S; Yanagihara K; Mikamo H; Kunishima H
    J Infect Chemother; 2022 Nov; 28(11):1536-1545. PubMed ID: 35964806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.
    Cornely OA; Nathwani D; Ivanescu C; Odufowora-Sita O; Retsa P; Odeyemi IA
    J Antimicrob Chemother; 2014 Nov; 69(11):2892-900. PubMed ID: 25074856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-Analysis.
    Li R; Lu L; Lin Y; Wang M; Liu X
    PLoS One; 2015; 10(10):e0137252. PubMed ID: 26444424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
    Johnson S; Louie TJ; Gerding DN; Cornely OA; Chasan-Taber S; Fitts D; Gelone SP; Broom C; Davidson DM;
    Clin Infect Dis; 2014 Aug; 59(3):345-54. PubMed ID: 24799326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and emerging therapies in treatment of Clostridium difficile infection.
    Goyal H; Perisetti A; Rehman MR; Singla U
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
    Wang Y; Schluger A; Li J; Gomez-Simmonds A; Salmasian H; Freedberg DE
    Clin Infect Dis; 2020 Dec; 71(9):2414-2420. PubMed ID: 31714955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
    Kimura T; Snijder R; Sugitani T
    J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
    Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
    Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes: a systematic review and meta-analysis.
    Stabholz Y; Paul M
    Clin Microbiol Infect; 2024 Jan; 30(1):51-58. PubMed ID: 37690610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan.
    Mikamo H; Tateda K; Yanagihara K; Kusachi S; Takesue Y; Miki T; Oizumi Y; Gamo K; Hashimoto A; Toyoshima J; Kato K
    J Infect Chemother; 2018 Sep; 24(9):744-752. PubMed ID: 29934056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
    Manthey CF; Eckmann L; Fuhrmann V
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1239-1250. PubMed ID: 28766951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.